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PERFORMANCE ASSESSMENT OF GA DISTRICT MUTUAL HEALTH INSURANCE
SCHEME IN THE GREATER ACCRA REGION IN GHANA
Nsiah-Boateng E
National Health Insurance Scheme (NHIS), Accra, Ghana
OBJECTIVES: Ghana established National Health Insurance Scheme (NHIS) in 2004
to replace out-of-pocket payment popularly referred to as ‘cash and carry’, which
created financial barrier to health care access to the poor and vulnerable. However,
the NHIS was fully implemented in 2005 and has since faced operational challenges
such as delays in issuance of membership cards to registered members and pay-
ment of providers claims. The study assessed performance of the Ga District Mu-
tual Health Insurance Scheme over the period, 2007-2009 and provided recommen-
dations to improve on its operations. METHODS: Desk review method was
employed to review membership, revenue, expenditure, and medical claims data
of the Scheme. A household survey was also conducted in the Madina township to
determine community coverage rate of the scheme. RESULTS: The study shows a
membership coverage of 22.6% and a community coverage of 22.2%. About one-
third of the registered members are paying premium to the scheme and this affects
revenue. Financially, the scheme depends largely on subsidies and reinsurance
from National Health Insurance Authority (NHIA) for 89.8% of its revenue. Approx-
imately 92% of the total revenue was spent on medical bills. About 99% of provider
claims are settled beyond the stipulated 4 weeks period. This poses financial chal-
lenge to healthcare providers and may force them to take measures that defeat the
purpose of the scheme. CONCLUSIONS: There are downward trends in member-
ship coverage and revenue from contributions. Also, there are lengthy delays in
claims settlements. Establishment of district schemes in the Ga East and Ga West
sub-districts will be necessary to improve membership coverage and revenue mo-
bilization from the informal sector. Whilst the claims are being vetted, it will be
important for the scheme to advance part-payment to healthcare providers to
ensure continuous provision of services to insured members.
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OBJECTIVES: To evaluate a possible switch from traditional pediatric hospitaliza-
tion to pediatric medical daycare in Belgium.METHODS:Observational prospective
survey was performed in 12 Belgian hospitals during fifteen days in autumn 2010.
Characteristics of the patients including main chronic pathology were recorded, as
were the cause of the hospitalization (work-up with or without anesthesia, treat-
ment with or without anesthesia, other) and the different acts possibly done.
RESULTS:Among the 592 children (16 years old), 41.3% had a chronic disease. The
most common conditions reported were neoplasia-related (61.0%). The main
causes to admit daycare were a work- up (46.9%) or a treatment (46.1%). 24.5% of the
children underwent anesthesia. 10.0% of all the technical acts performed were
neoplasia-related (chemotherapy, blood transfusion. . .), which means that 90% of
the acts were not neoplasia-related and could have be done regardless of any
chronic condition. CONCLUSIONS: According to international convention and pa-
rental will, traditional overnight hospitalization of a child, if not avoidable, should
be as short as possible. If there is no need of special techniques (e.g. O2therapy) or
an overnight treatment, a short stay in a pediatric medical daycare unit helps
treating children without conventional hospitalization, regardless of an eventual
chronic condition.
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ARE OLDER MOTHERS MORE PRONE TO HAVING CHILDREN WITH
DISABILITIES? LIFETIME DISABILITY OUTCOMES VERSUS MULTIPLE BIRTH
REDUCTIONS ARISING FROM IN-VITRO FERTILIZATION (IVF) TREATMENTS IN
CANADA
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OBJECTIVES: We investigated the clinical and economic consequences of reduc-
tions in multiple births disabilities, according to mothers’ age, resulting from
switching from private to public provisions of IVF services in Canada. METHODS:
Using the Canadian Fertility Cost Model we estimated the potential decrease in
lifetime disability rates arising from the reduction of multiple pregnancies. Net
lifetime disability rates/costs were compared across mothers’ ages 28 to 45, by
singleton, twin, and triplet births. Probabilistic sensitivity analyses were per-
formed to account for the effect of uncertainty in lifetime disability rates/costs.
Incremental net benefits (INB) of reducing multiple births, confidence intervals
around the INB and cost-effectiveness acceptability curves (CEAC) are reported.
RESULTS: Assuming reductions in multiple birth rates equal to those reached by
selected European countries, where pregnancy rates are unaffected by decreases in
multiple birth rates, the proportions of multiple births could be reduced from 28.8%
to 13.4%. Switching from private to public provisions (multiple birth reduction
scenario), lifetime disability rates for multiple birth rates are lower in older woman
(40), due to low birth success rates, hence low multiple births. For women under
35, aged 35-39, and over 40, net reductions in lifetime disability due to decreases in
multiple births are 3.6%, 3.2% and 2.6%. Women under 35, aged 35-39 and over 40
had cost savings of $31 M, $22 M and $4.5 M per 1% decrease in net lifetime disabil-
ity. Within a range of $150 M and $558 M, the proportion of the total cost savings,
attributable to mothers in the three age groups are 56%, 38%, and 6%, respectively.
CONCLUSIONS: Majority of potential cost savings accrues to women under 40
years old. Relatively higher reductions in lifetime disability in younger women
indicate that efforts to reduce multiple births should primarily be aimed at woman
under 40 years old.
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OBJECTIVES: The physical exercise is known to associate with multiple changes in
blood haemostasis parameters in healthy individuals. METHODS: In the current
study haemostatic alterations induced by physical exercise were measured by ro-
tational thrombelastometry (ROTEM, Pentapharm) in 13 healthy sportsmen and 10
healthy sportswomen. Venous blood was drawn immediately before and after fin-
ishing spiroergometry for rotational thrombelastometry analyses. The 3 basic ded-
icated ROTEM test applications NATEM (recalcification), INTEM (intrinsic pathway)
and EXTEM (extrinsic pathway) were performed. The following key parameters
were recorded: clotting time (CT), clot formation time (CFT), alpha angle, maximum
clot firmness (MCF), maximum lyses (ML), amplitude reduction 5,-10,-15,-20 min
after MCF (A5, A10, A15, A20). Statistical analysis was performed using the
Wilcoxon-test. RESULTS: In case of sportsmen all significant statistical differences
related with physical exercise were obtained by NATEM (but not with INTEM or
EXTEM) measurements. After the exercise the mean CT was shorter (315.7/ 91.8
seconds vs. 255.3 / 75.9 seconds, P .039). The MCF was broader (53.9 / 4.23
mm vs. 65.0/ 12.87 mm, P .004). In case of sportswomen the MCF was broader
after exercise (60,0/3,7 mm vs. 66,7/10,4 mm, P .04) by NATEM measure-
ments. Other parameters were not statistically significant. Emphasize the impor-
tance of change in CT values which were decreasing after exercise but did not reach
the significant level.CONCLUSIONS:On the basis of our data we could demonstrate
that ROTEM is sensitive to exercise-induced hemostatic alterations. It was shown
that during physical load hyper-coagulation processes occurred. In this processes
there seem not to be differences due to gender. Our study might be able to help
point out the differences in exercise-induced alterations of hemostatic regulation
related to gender.
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OBJECTIVES: In 1996 PAHO/WHO and UNICEF developed the IMCI strategy with the
aim of improving the health workers’ performance, strengthening the health sys-
tem support and improving the knowledge about the children care best practices at
home and in the community. The objective of this study is to evaluate the IMCI
strategy through the health managers’ perceptions. METHODS: Qualitative design
using semi-structured interview. Population Study: key persons, governmental
and nongovernmental health organizations managers who participated in the IMCI
strategy in the State of Ceará (Northeast Brazil) and in Peru. The interviews were
conducted during May-June 2011. They were tape recorded and transcribed later.
For the analysis, a triangulation method was carried out with another researcher,
reviewing the literature and other documents. RESULTS: An important reduction
in infant mortality rate was observed in Ceará (from 32 per 1000 live births in 1997
to 15.6 in 2009) and in Peru (from 43 per 1000 live births in 1996 to 17 in 2008) by the
decrease in post-neonatal mortality due to diarrhea and pneumonia. In both places
at the beginning there was a large-scale training for the health staff, doctors and
nurses, and less for the community health agents. The evolution of the strategy has
been different. In Ceará there was a decrease of the interest and a lack of support
from governments. In Peru, the government adopted the strategy; likewise there
was a greater incorporation into the university teaching, distance learning and the
addition incorporation of new content (perinatal/neonatal, asthma and broncho-
obstructive syndrome, child development, oral health, abuse, violence and acci-
dents, diabetes and obesity).CONCLUSIONS:The IMCI strategy has been developed
differently in the studied countries. This information can be used to evaluate the
strategy and the participation of the different sectors responsible for the child
health.
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COMPARATIVE PRICING AND REIMBURSEMENT ANALYSIS IN FOUR EAST
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OBJECTIVES: To analyse and compare the pricing and reimbursement procedures
of pharmaceuticals in Bulgaria (BG), Czech Republic (CZ), Poland (PL), and Romania
(RO). METHODS: Health legislation including corresponding laws and regulations
determining pricing and reimbursement procedures was reviewed. Countries were
selected on the basis of their mutual referencing. RESULTS: In all four countries
health insurance is obligatory and medicines prices are regulated applying the
reference pricing system for prescription medicines. In BG, RO and PL positive drug
lists constitute reimbursement approach. Bulgaria’s reference countries include
RO and CZ, not PL. Romania’s reference basket encloses 12 countries including BG
A408 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 2 3 3 - A 5 1 0
and CZ, while PL references to all EU countries. CZ and RO employ the average
among the three lowest reference prices and BG and PL the lowest reference price.
There is a regressive margin scale in all countries. In BG, RO and PL margins are
separated for wholesalers and retailers, while in CZ they are negotiated. In CZ and
PL there are multiple insurance companies compared to BG and RO, where there is
only one. Currently RO’s reimbursement is 50% of the price for all prescription
drugs, BG and PL use 4 reimbursement levels, PL and CZ employ a complex external
and internal referencing. In CZ the reimbursement base is the cheapest medicinal
price in the group. In BG, PL and RO the reimbursement level is the cheapest price
per DDD for every INN. All countries require pharmacoeconomic evidences, but CZ
and PL employ guidelines, while BG and RO apply criteria for evaluation.
CONCLUSIONS: We deem BG and RO systems less adaptable, but clearer to follow.
CZ and PL systems show greater flexibility, due to existence of negotiation and
freedom.
Individual’s Health – Research on Methods
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OBJECTIVES: Despite nearly 25 years of experience with recombinant human
growth hormone (GH) treatment modalities vary significantly between centres and
regions and final outcome of GH therapy varies widely . In a country like Germany,
for example, children with growth disorders are treated with Genotropin® (Pfizer
Inc, New York) in more than 150 institutions with different levels of experience.
METHODS: Data collected from more than 75,000 children with growth disorders
treated with Genotropin are followed-up worldwide in a large, pharmaco-epidemi-
ological database (KIGS, Pfizer International Growth Study). Country specific data-
sets are used to compare treatment standards and demonstrate differences be-
tween individual centres and the country as a whole. Site-specific, individualized
reports enable clinicians to anonymously benchmark the quality of care in their
treatment centre. Quality indicators (like diagnostic tests, height and height veloc-
ity, GH dose, treatment response and responsiveness, treatment duration, adverse
events, completeness of documentation) are followed and compared. RESULTS:
Structural aspects as well as process and outcome indicators differed between the
paediatric endocrinology centres, e.g. age at start of therapy, GH doses and diag-
nostic procedures. The reports allowed self-audit of clinical practice, sharing of
best practice and promote discussion of clinical decision making in paediatric
specialist care forums. CONCLUSIONS: The KIGS Quality Insight (KIGS QI) program
provides a successful approach to unmask deficits and to improve the outcome of
care. The output from the centre and country specific analysis allows identification
and follow-up of GH non-responders and assists with demonstration of standard of
care and treatment outcomes in the country to hospital managers, guidelines com-
mittees and payers. Results from KIGS can be successfully used to enable investi-
gators to compare their treatment centre with the country as a whole and to assess
changes over time.
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FEMALE URINARY INCONTINENCE IN GERMANY– COST EXPLOSION
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OBJECTIVES: To estimate costs of routine care for female urinary incontinence in
nursing care in Germany. The management of female urinary incontinence is con-
sidered as the most cumbersome task in nursing homes for the elderly. Despite the
great economic burden of incontinence, the largest cost category, routine care
costs, is poorly described, and there are limited data on cost in nursing homes
METHODS: In cooperation with a nursing home, cost of managing incontinent
patients was evaluated. Both direct patient-material and laundry costs were con-
sidered. Time required to manage an incontinent patients was also evaluated. Data
were collected on randomly selected female patients. The determination of the
cost was based on the existing prices and the usual salary of employees in nursing
homes. RESULTS: Total cost of managing an incontinent patient sums up to
€2260.06/month/patient. Cost calculation of nursing care was based on a 4 times/
day changing of diapers. This accounted in total €434.40 for the material costs
(anatomical pads, disposable gloves, hand and surface disinfectants, incontinence
bed cover, mattress protectors, pants, wound cream, protective aprons and dia-
pers). The costs for the nursing staff work amounted to €1825.66. The results are in
contrast to the publication of Schulenburg et. al who analyzed the material costs in
German Health Care System by incontinence patients. The annual costs were cal-
culated with 261 €. Personnel costs were not calculated. CONCLUSIONS: Female
urinary incontinence demands highest attention and should not be taken as symp-
tom of aging. Rather, the urinary incontinence is treatable disease, which improves
the quality of life and reduces the cost of health care. Female urinary incontinence
should be perceived as a widespread disease. Approaches would include the de-
velopment of a disease management program and the implementation in German
social act.
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OBJECTIVES:Neisseria meningitidis (Nm) is a leading cause of bacterial meningitis
and bacteremia worldwide. While infection (or carriage) is common throughout a
person’s life history, invasive meningococcal disease (IMD) is rare and is dispro-
portionately observed in infants and adolescents. Previous models that evaluated
the health and economic impact of meningococcal vaccines have not always con-
sidered key epidemiological features such as transmission mechanisms, or risk of
IMD outbreaks. Our objective was to understand which natural history assump-
tions best matched the observed time trends in disease notification data, in order to
use the most realistic model to economically evaluate new meningococcal vacci-
nation policies. METHODS: We formulated two dynamic stochastic compartmen-
tal models of Nm transmission within a population of hosts: the first assumed
transient natural immunity entailing perfect cross-protection between serogroups;
the second assumed partial (and thus imperfect) cross-immunity amongst sero-
groups. In both models, Nm infection and IMD were assumed to be distinct sto-
chastic processes and IMD was assumed to occur in a small fraction of the popu-
lation at the time infection is acquired. RESULTS: Model parameters were
calibrated to carriage data and 62-year case notification data from Canada. Sus-
tained oscillations and co-circulation of multiple serogroups are ubiquitous in the
IMD case notification data of many countries. Only the second model captured
these patterns, while the first model unrealistically predicted that one serogroup
would always disappear from the population. CONCLUSIONS: The predicted im-
pact of various meningococcal vaccines will likely depend strongly on assumptions
about strain interactions, some of which lead to dynamics that are inconsistent
with observations. While empirical unknowns about strain interactions between
Nm serogroups remain, our results suggest that cross-protection and natural im-
munity assumptions significantly impact predicted multigroup dynamics, and
hence may affect predictions of the health and economic impact of new vaccina-
tion policies.
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TRAIT OR STATE: AN EXPLORATION OF SELF-ESTEEM, HAPPINESS AND
QUALITY OF LIFE BY TIME SERIES
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OBJECTIVES: Mainstream of psychological researches usually utilizes large sam-
ples, cross-sectional studies and aggregate frames to analyze data and interpret
them. However, the limitations are that the specific features of individuals are not
easy to be revealed and the time effect has been ignored. This study explores both
of the trait-like and state-like properties including global self-esteem, happiness
and the quality of life. By using time series analysis which can examine individual,
longitudinal and non-aggregate data, the properties of psychological measures can
be investigated. METHODS: Ten college students (mean age20.6 year, SD2.18)
and four adults (mean age30.27 year, SD1.23) participated in this study. Each
subject completed six 10-cm visual analogue scale items, once a day for 2 months.
These items measure subject’s global self-esteem, happiness, the quality of life,
positive life events, negative life events as well as random error (i.e., Participant
was asked to make a mark on the center of a line). Time series analysis, including
autoregressive and moving average modeling procedures, was used to examine the
time dependency (i.e., more trait-like) for each item. RESULTS: For the college
sample, 80% of autocorrelation and partial-autocorrelation coefficients were not
significant across time lag. This result doesn’t fully support the existence of time
dependency for each item. On the contrary, 55% of autocorrelation and partial-
autocorrelation coefficients were statistically significance for the adult sample.
Both samples showed significant correlations among psychological measures (self-
esteem, happiness and the quality of life) and life events (positive and negative).
CONCLUSIONS: In conclusion, the results support that self-esteem, happiness and
quality of life may contain both trait-like and state-like properties, and the time
dependency of psychological measures is more stable especially in adults.
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MODELS TO ESTIMATE HEIGHT OUTCOME FOLLOWING GROWTH HORMONE
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OBJECTIVES: Annual growth prediction models following growth hormone (GH)
treatment have been developed to facilitate treatment guidance. However, accu-
rately predicting height over the long term, during pre-pubertal treatment years
has not been assessed and is a prerequisite for modelling of cost effective optimum
height outcomes. METHODS: Annual prediction models utilised data from large
cohorts sourced from the KIGS database (Pfizer International Growth Database,
comprising 75,000 children with growth disorders) and describe the likely annual
height gain based on patients’ auxological and biochemical characteristics (e.g. GH
dose, age, mid parental height standard deviation [SDS] and weight SDS score) at
treatment start. The most likely long-term height development was simulated
prospectively up to 4 years by sequential application of existing yearly prediction
algorithms for height velocity (HV) and newly developed algorithms for weight gain
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